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Case Report
Giant Cell (Temporal) Arteritis With Anterior Ischemic
Optic Neuropathy: A Biopsy-proven Case in Taiwan
Cheng-Kuo Cheng,1,2,3* Chin-Cheng Lee,4 Kai-Han Huang,1 Tzu-En Wu,1 Pai-Huei Peng1
Giant cell arteritis with arteritic anterior ischemic optic neuropathy has rarely been diagnosed in Taiwan.
Recently, we encountered a 76-year-old Taiwanese patient who presented with right visual impairment and
marked pale swelling of his right disc. He also suffered body weight loss, general malaise and many typical
manifestations of giant cell arteritis, such as jaw claudication, a tender, non-pulsating engorgement of his
temporal arteries, and a highly elevated erythrocyte sedimentation rate and C-reactive protein level. Biopsy
of his right superficial temporal artery revealed a granulomatous inflammation with multinucleated giant
cell infiltration. This was a biopsy-proven case of giant cell arteritis with arteritic anterior ischemic optic
neuropathy and indicated that although rare, this disease could occur in patients in Taiwan.
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Giant cell arteritis (GCA), also referred to as tem-
poral arteritis, is an inflammatory vasculitis that
mainly involves large and medium vessels, partic-
ularly the cranial branches of the aorta. Superficial
temporal, occipital, vertebral, ophthalmic and pos-
terior ciliary arteries are the most frequently 
affected vessels. It has a predilection for elderly
patients, with a mean presenting age of 70 years.1
Ocular involvement might occur in up to 50–70%
of patients with GCA1,2 and represents a true
ophthalmic emergency because the possibility of
visual loss is very high if it is not recognized and
treated promptly.1
The incidence of GCA varies widely in different
areas throughout the world. In Caucasian people,
the disease is not uncommon.3 The highest world-
wide incidence of GCA occurs in Scandinavia, with
an annual incidence between 20.4 and 32.8 per
100,000 for the population aged >50 years. In con-
trast, the incidence is generally very low in African,
Hispanic and Asian countries.3 Although the inci-
dence among the Chinese is not known, it is be-
lieved to be very low. As far as we are aware, there
have only been a few anecdotal case reports in the
literature.4–8 In Taiwan, biopsy-proven cases of
GCA are even rarer.9 Recently, we examined and
treated an elderly Taiwanese patient with anterior
ischemic optic neuropathy (AION) and many typ-
ical manifestations of GCA, such as jaw claudica-
tion, a tender, non-pulsating engorgement of the
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temporal artery, and highly elevated erythrocyte
sedimentation rate (ESR) and C-reactive protein
(CRP) level. Biopsy of his right superficial tempo-
ral artery revealed a granulomatous inflamma-
tion with multinucleated giant cell infiltration.
Because of the paucity of studies of GCA in Taiwan,
we believe that this report could be beneficial to
our colleagues.
Case Report
A 76-year-old Taiwanese man of Chinese descent
with sudden onset of painless visual field loss
and visual decrease in his right eye for 5 days was
referred to our ophthalmological department on
September 27, 2007. Visual field testing in the
local clinic showed severe arcuate scotoma of his
right eye and mild arcuate scotoma of his left eye
(Figure 1). He had been suffering scalp tenderness
that radiated to the bilateral temporal area, and jaw
claudication for 6 weeks. Anorexia, general malaise
and body weight loss were also noted during this
period. He had a 3-year history of diabetes melli-
tus under good medical supervision. No chest pain
or breathing difficulty was noted. The right vision
deteriorated very quickly from 6/7.5 to 6/20 in 
2 days. He was then admitted for further treat-
ment. On examination, his best corrected visual
acuity was 6/20 in the right eye and 6/6 in the left.
The intraocular pressure of his right and left eye
was 9 mmHg and 7 mmHg, respectively. Both
eyes were freely movable and non-tender upon
eye movement. A relative afferent pupillary defect
of light reflex was noted in his right eye. Ophthal-
moscopic examination revealed a pale swelling
of the right optic disc (Figure 2). A mild color
disturbance was noted on an Ishihara color plate
test (5/15 errors, normal ≤ 4/15) and a Farnsworth
D-15 color discrimination test (one error line in
OS OD
Figure 1. An automatic visual field test showed more marked arcuate scotomata of both upper and lower field of right
eye (OD) than left eye (OS).
OD OS
Figure 2. Fundus pictures showed marked pale swelling of the right optic disc (OD) as compared to left optic disc (OS).
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the yellow-green confusion axis) of his right eye.
Both superficial temporal arteries were engorged,
hardened and non-pulsating (Figure 3). Investi-
gation revealed an ESR of 114 mm/hr and a CRP
level of 2.11 mg/dL (normal, < 0.5 mg/dL). His
hemoglobin was 13.0 g/dL and the blood cell
profile was within normal limits. The serum an-
ticardiolipin antibody was 13.8 GPLU (normal,
< 11 GPLU). A chest X-ray, renal and liver function
tests, other immunological factors such as anti-
nuclear antibody, and brain magnetic resonance
imaging were all normal.
A biopsy of the right superficial temporal ar-
tery of about 10 cm in length was performed. The
histopathological examination revealed duplica-
tion and fragmentation of the internal elastic lam-
ina of the artery. The vascular wall was thickened
and was infiltrated with lymphocytic and multi-
nucleated giant cells (Figure 4).
The patient was treated with 1 mg/kg/day oral
prednisolone. The patient’s symptoms improved
rapidly, with subsidence of jaw claudication, gen-
eral malaise and temporal headache. The ESR 
decreased to 19 mm/hr and CRP level decreased to
< 0.1 mg/dL within 10 days of treatment. The vi-
sual acuity improved after treatment and recovered
2 months later, going from 6/20 to 6/8.6. At the
time of the preparation of this article, the patient
was still being treated with oral prednisolone on
a careful tapering schedule, with monthly moni-
toring of ESR and CRP level for over 6 months.
Discussion
This article presents a case of arteritic anterior is-
chemic optic neuropathy (A-AION), with typical
pathological findings of multinucleated giant cell
infiltration of the temporal artery in a Taiwanese
patient of Chinese descent. To the best of our
knowledge, there has been no report of a biopsy-
proven case of A-AION in Taiwan. In 2005, Chen
et al9 reported on two Taiwanese GCA patients
with headache and general malaise. Biopsies of the
temporal arteries of these patients showed lym-
phocytic and mononuclear cell infiltration. In
one patient, there were occasional multinucleated
giant cells found on microscopic examination.
However, unlike our patient, neither of these pa-
tients had ocular symptoms and signs of ischemic
optic neuropathy.
A-AION is the most frequent ocular compli-
cation of GCA. It can cause acute visual loss in
Figure 3. Bilateral superficial temporal arteries showed en-
gorgement and torturosity (upper: right side, lower: left side).
Figure 4. The histopathological examination of right super-
ficial temporal artery biopsy revealed thickened vascular
wall with infiltration of lymphocytes and multinucleated
giant cells. (Inlet) A typical multinuclear giant cell.
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one or both eyes. Pale disc edema with occasional
splinter hemorrhages at the disc margin can be
seen on ophthalmoscopic examination. Visual loss
varies from a minimal disturbance to profound
impairment with no light perception. Visual field
defects most often include an altitudinal hemi-
visual field defect, a sector defect, or a central
scotoma. Sometimes, other types of visual field
defects can be found.1 Our case presented with a
visual disturbance in the right eye and pale swell-
ing of the optic disc. The visual field defect in our
case showed arcuate scotomata of the upper and
lower visual fields. Although the patient did not
complain of visual disturbance in his left eye, the
left visual field test also revealed a mild periph-
eral arcuate visual field defect, which suggested
early involvement of his left eye. It is fortunate
that the visual disturbance had not yet progressed
to the catastrophic status, and could be recovered
to a mild subnormal level after prompt treatment.
Ischemic optic neuropathy usually progresses very
rapidly; therefore, prompt treatment with an ad-
equate dosage of steroids is essential to save visual
function. Involvement of the fellow eye is also a
frequent complication, even during steroid ther-
apy.1 Close follow-up of the fellow eye while treat-
ing these patients is important.
In our case, the combination of typical systemic
signs and symptoms and an AION led us to sus-
pect GCA. The elevated ESR and CRP level indi-
cated the need for prompt steroid treatment and
biopsy of the superficial temporal artery. ESR and
CRP level are considered the most highly predic-
tive laboratory factors of CGA, with a combined
sensitivity of up to 99.2%.10,11 They are also very
useful for monitoring GCA activity and regulating
steroid therapy. Our case had an ESR of 114 mm/hr
and a CRP level of 2.11 mg/dL, which were far
above normal levels. In the treatment course of
this patient, ESR and CRP level were regularly
checked in order to monitor the disease and the
effectiveness of steroid treatment.
In our case, anticardiolipin antibody was ele-
vated. Anticardiolipin antibodies can be present in
up to 50% of patients with GCA.12 In long-term
follow-up of 58 patients with biopsy-proven GCA,
Liozon et al13 found that increased serum levels
of anticardiolipin antibodies correlate well with
clinical recurrence during or after treatment, and
might help exclude infection as a cause of recur-
rent symptoms. However, their significance and
the association with ischemic complications or
ocular complications of GCA are still not fully
understood.12
Temporal artery biopsy (TAB) is the gold 
standard for diagnosis of GCA. To establish the
diagnosis and prevent treatment delay of this 
potentially blinding disease, TAB should be per-
formed as soon as possible in every patient sus-
pected of having GCA or A-AION.1 The American
College of Rheumatologists have proposed crite-
ria for the histological diagnosis of GCA, which in-
clude histological evidence of necrotizing arteritis
in the temporal artery, with predominantly mono-
nuclear cell infiltration or granulomatous inflam-
mation, usually with multinucleated giant cells.14
Although the presence of giant cells in the biopsy
is not essential for pathological diagnosis, some
authors have advocated that the presence of giant
cells might be associated with a higher rate of vi-
sual impairment.15 False negative results have been
reported in 5–13% of temporal artery biopsies in
GCA cases. The rate of false negatives might be as-
sociated with the length of the specimen obtained,
the presence of skip lesions, pathological sec-
tioning techniques, and duration of treatment
before biopsy. To reduce the chance of false neg-
ative results caused by skip lesions, it is recom-
mended that, in TAB, at least a 2.5-cm section is
obtained, together with more closely spaced sec-
tions (0.25 mm or 0.5 mm) for pathological exam-
ination.1 A long TAB (about 10 cm) was performed
in our case, which revealed typical pathological fea-
tures of granulomatous inflammation of arterial
walls, with infiltration of multinucleated giant cells
and mononuclear cells. It provided unequivocal
evidence for the diagnosis of GCA and support
for continued treatment with corticosteroid.
In conclusion, this report presented a biopsy-
proven case of CGA with A-AION and indicated
that, although very rare, it can occur in patients
in Taiwan. A high sensitivity to the signs and
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symptoms of GCA in every AION case, a rapid di-
agnostic work-up such as ESR, CRP and TAB, and
prompt treatment with corticosteroid could be
necessary to save the vision of patients with com-
plications of GCA.
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